Jove
Visualize
Contact Us

Related Experiment Videos

[Psoriasis, a systemic disease?].

L Puig-Sanz1

  • 1Servicio de Dermatología, Hospital de la Santa Creu i Sant Pau, Barcelona, España. lpuigs@meditex.es

Actas Dermo-Sifiliograficas
|August 1, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prenatal Screening for Bathing-suit Ichthyosis After Diagnosis in an Older Sibling.

Actas dermo-sifiliograficas·2015
Same author

[Feasibility and reliability of the Spanish version of the Leeds Revised Acne Grading Scale].

Actas dermo-sifiliograficas·2010
Same journal

Fingolimod-associated lymphomatoid papulosis.

Actas dermo-sifiliograficas·2026
Same journal

Demodicosis: update and treatment with laser and other light sources.

Actas dermo-sifiliograficas·2026
Same journal

New treatments for adult female acne.

Actas dermo-sifiliograficas·2026
Same journal

First regulations of the Spanish Society of Dermatology (1909).

Actas dermo-sifiliograficas·2026
Same journal

Long-hair FUE: advantages and disadvantages of the most recent technique in hair transplantation.

Actas dermo-sifiliograficas·2026
Same journal

Sunburns, Tanning, and Social Media: A Descriptive Study Among Spanish University Students.

Actas dermo-sifiliograficas·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Psoriasis patients face higher risks of cardiovascular disease due to shared inflammation pathways and metabolic syndrome. Early recognition and treatment of metabolic syndrome elements are crucial for managing psoriasis comorbidities and reducing mortality.

Area of Science:

  • Dermatology
  • Cardiology
  • Metabolic Diseases

Background:

  • Psoriasis, particularly severe forms, is epidemiologically linked to conditions like arthritis and Crohn's disease, sharing a common TNF-alpha pathway.
  • Patients with severe psoriasis exhibit a higher prevalence of obesity, dyslipidemia, diabetes mellitus, alcohol abuse, and smoking, increasing atherosclerosis risk.
  • Metabolic syndrome, characterized by abdominal obesity, atherogenic dyslipidemia, hypertension, and insulin resistance, is a recognized cardiovascular disease risk factor.

Purpose of the Study:

  • To highlight the pathogenic role of chronic inflammation in metabolic syndrome within psoriasis patients.
  • To emphasize the importance of recognizing and managing metabolic syndrome components in psoriasis management.
  • To underscore the need for integrated dermatologic and metabolic care to reduce cardiovascular risk.

Related Experiment Videos

Main Methods:

  • Review of epidemiological associations between psoriasis and other diseases.
  • Analysis of shared pathogenic substrates, including TNF-alpha.
  • Examination of the role of chronic inflammation in metabolic syndrome and comorbidities.

Main Results:

  • Chronic inflammation plays a pathogenic role in metabolic syndrome and associated comorbidities in psoriasis.
  • Adequate treatment of inflammation may help reverse metabolic syndrome and its complications.
  • Dermatologists are urged to identify metabolic syndrome elements in psoriasis patients.

Conclusions:

  • Integrated management of psoriasis, including lifestyle changes and pharmacotherapy, is essential.
  • Addressing metabolic syndrome components can mitigate cardiovascular morbidity and mortality in psoriasis patients.
  • Early intervention by dermatologists can significantly impact patient outcomes by reducing cardiovascular risk.